Lv1
26 积分 2023-12-27 加入
CD4+ T cells in cancer
4个月前
已完结
T cell-based cancer immunotherapy: opportunities and challenges
4个月前
已完结
The ins and outs of MHC class II-mediated antigen processing and presentation
4个月前
已完结
实体肿瘤外周血细胞免疫功能实验室检测专家共识
4个月前
已完结
Efficacy and safety of tazemetostat in patients with refractory/relapsed follicular lymphoma or diffuse large B cell lymphoma: Systematic review and meta analysis
4个月前
已关闭
Data from Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell–like Type: Phase II Clinical Trial of the Spanish GELTAMO Group
4个月前
已关闭
First‐in‐Human (FIH) Study of the Fully‐Human Kappa‐Lambda CD19/CD47 Bispecific Antibody TG‐1801 in Patients with B‐Cell Lymphoma
4个月前
已关闭
Interim Results of the Phase 1 Study of Tnb-486, a Novel CD19xCD3 T-Cell Engager, in Patients with Relapsed/Refractory (R/R) B-NHL
4个月前
已完结
PF-08046032: A Novel, Investigational CD25-Directed Antibody–Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
4个月前
已完结
皖公网安备34019202002308
